SciSparc (SPRC) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

SciSparc Revenue Highlights


Latest Revenue (Y)

$2.88M

Latest Revenue (Q)

$907.00K

SciSparc Revenue by Period


SciSparc Revenue by Year

DateRevenueChange
2023-12-31$2.88M113.73%
2022-12-31$1.35M26.01%
2021-12-31$1.07M94.36%
2020-12-31$550.00K10.44%
2019-12-31$498.00K-40.57%
2018-12-31$838.00K72.07%
2017-12-31$487.00K100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

SciSparc generated $2.88M in revenue during NA 2023, up 113.73% compared to the previous quarter, and up 343.56% compared to the same period a year ago.

SciSparc Revenue by Quarter

DateRevenueChange
2023-12-31$907.00K-54.01%
2023-06-30$1.97M46.40%
2022-12-31$1.35M100.00%
2022-06-30--100.00%
2021-12-31$1.07M100.00%
2021-06-30--100.00%
2020-12-31$550.00K100.00%
2020-06-30--100.00%
2019-12-31$498.00K100.00%
2019-06-30-100.00%
2019-03-31--100.00%
2018-12-31$838.00K100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31$487.00K100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2013-12-31--

SciSparc generated $907.00K in revenue during Q4 2023, up -54.01% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

SciSparc Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
YSLakeShore Biopharma$687.20M$164.98M
CTMXCytomX Therapeutics$101.21M$25.11M
ASMBAssembly Biosciences$7.16M$5.79M
SPRCSciSparc$2.88M$907.00K
UNCYUnicycive Therapeutics$675.00K-
VRAXVirax Biolabs Group$8.56K$76.50K
PXMDPaxMedica--
TILInstil Bio--
REVBRevelation Biosciences--
HILSTharimmune--
CVKDCadrenal Therapeutics--
NLTXNeurogene--
HOTHHoth Therapeutics--
ZVSAZyVersa Therapeutics--
ONCSOncoSec Medical--
VIRIVirios Therapeutics--
NUVBNuvation Bio-$1.44M
QNRXQuoin Pharmaceuticals--
KPRXKiora Pharmaceuticals-$20.00K
CDIOCardio Diagnostics-$7.87K
BWVOnconetix--

SPRC Revenue FAQ


SciSparc's yearly revenue for 2023 was $2.88M, representing an increase of 113.73% compared to 2022. The company's yearly revenue for 2022 was $1.35M, representing an increase of 26.01% compared to 2021. SPRC's yearly revenue for 2021 was $1.07M, representing an increase of 94.36% compared to 2020.

SciSparc's quarterly revenue for Q4 2023 was $907K, a -54.01% decrease from the previous quarter (Q2 2023), and a -15.15% decrease year-over-year (Q4 2021). The company's quarterly revenue for Q2 2023 was $1.97M, a 46.40% increase from the previous quarter (Q4 2022), and a 0% increase year-over-year (Q2 2021). SPRC's quarterly revenue for Q4 2022 was $1.35M, a 100.00% increase from the previous quarter (Q2 2022), and a 144.91% increase year-over-year (Q4 2020).

SciSparc's revenue growth rate for the last 3 years (2021-2023) was 169.32%, and for the last 5 years (2019-2023) was 478.11%.